Skip to main content

Table 3 Support recommended by participants to increase MOUD receipt among patients with co-occurring substance use

From: Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings

•Create clear institutional policies/guidelines related to providing buprenorphine to patients with co-occurring substance use

•Provide more specific education/training to providers outside of SUD specialty settings related to treating OUD among patients with co-occurring substance use

•Increase collaboration between buprenorphine providers outside of SUD specialty settings and SUD specialists

•Give buprenorphine providers outside of SUD specialty settings more time to spend with each patient

•Increase nursing and other staff

•Increase same-day availability

•Increase availability of SUD specialty services

•Improve linkage to SUD specialty services (integrate SUD care into other settings, co-locate SUD clinics with other clinics, improve referral and warm hand-off processes)

  1. MOUD medications for opioid use disorder, OUD opioid use disorder, SUD substance use disorder
Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640